GB201304699D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB201304699D0
GB201304699D0 GB201304699A GB201304699A GB201304699D0 GB 201304699 D0 GB201304699 D0 GB 201304699D0 GB 201304699 A GB201304699 A GB 201304699A GB 201304699 A GB201304699 A GB 201304699A GB 201304699 D0 GB201304699 D0 GB 201304699D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201304699A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMACEUTICAL ORIENTED SERVICES Ltd
REMEDICA Ltd
Original Assignee
PHARMACEUTICAL ORIENTED SERVICES Ltd
REMEDICA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMACEUTICAL ORIENTED SERVICES Ltd, REMEDICA Ltd filed Critical PHARMACEUTICAL ORIENTED SERVICES Ltd
Priority to GB201304699A priority Critical patent/GB201304699D0/en
Publication of GB201304699D0 publication Critical patent/GB201304699D0/en
Priority to EP14727714.9A priority patent/EP2968175A1/en
Priority to PCT/EP2014/054173 priority patent/WO2014139836A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
GB201304699A 2013-03-15 2013-03-15 Pharmaceutical compositions Ceased GB201304699D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB201304699A GB201304699D0 (en) 2013-03-15 2013-03-15 Pharmaceutical compositions
EP14727714.9A EP2968175A1 (en) 2013-03-15 2014-03-04 Pharmaceutical compositions comprising imatinib
PCT/EP2014/054173 WO2014139836A1 (en) 2013-03-15 2014-03-04 Pharmaceutical compositions comprising imatinib

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201304699A GB201304699D0 (en) 2013-03-15 2013-03-15 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB201304699D0 true GB201304699D0 (en) 2013-05-01

Family

ID=48226404

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201304699A Ceased GB201304699D0 (en) 2013-03-15 2013-03-15 Pharmaceutical compositions

Country Status (3)

Country Link
EP (1) EP2968175A1 (en)
GB (1) GB201304699D0 (en)
WO (1) WO2014139836A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4940418A1 (en) 1997-07-18 2000-07-24 Novartis Ag MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL-2-PIRIMIDINAMINE, PROCESSES FOR ITS MANUFACTURE AND USE
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20130011477A1 (en) * 2010-03-29 2013-01-10 Hetero Research Foundation Stable Pharmaceutical Composition of Imatinib
EA029416B1 (en) * 2010-06-21 2018-03-30 Заклады Фармацеутицне Польфарма Са Tablet comprising imatinib or a pharmaceutically acceptable salt thereof and process for the preparation thereof
TR201010618A2 (en) * 2010-12-20 2012-07-23 Bi̇lgi̇ç Mahmut An oral dosage form comprising imatinib and the manufacture of an oral dosage form
WO2013008253A2 (en) * 2011-07-11 2013-01-17 Dr. Reddys Laboratories Limited Imatinib formulations

Also Published As

Publication number Publication date
EP2968175A1 (en) 2016-01-20
WO2014139836A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
IL288961A (en) Pharmaceutical compositions
SI3030262T1 (en) Combined pharmaceutical composition
PL2943181T3 (en) Pharmaceutical compositions
GB201304662D0 (en) Compositions
PL3043778T3 (en) Pharmaceutical compositions containing refametinib
GB201313615D0 (en) Compositions
ZA201408333B (en) Pharmaceutical compositions
EP2990038A4 (en) Solid pharmaceutical composition
EP3003324A4 (en) Pharmaceutical compositions
SG11201601477VA (en) Pharmaceutical composition
SG11201509194SA (en) Radiomitigating pharmaceutical formulations
ZA201506637B (en) Micronized pharmaceutical compositions
ZA201601645B (en) Bendamustine pharmaceutical compositions
HRP20171888T1 (en) Pharmaceutical compositions
HUP1300496A2 (en) Stable pharmaceutical composition
HK1220143A1 (en) Pharmaceutical composition
GB201320962D0 (en) Compositions
GB201304699D0 (en) Pharmaceutical compositions
GB201320959D0 (en) Compositions
GB201321497D0 (en) Pharmaceutical compositions
GB201312851D0 (en) Pharmaceutical compositions
GB201304625D0 (en) New pharmaceutical composition
GB201312224D0 (en) Compositions
GB201304927D0 (en) Compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)